Study guide

7.1 Patient Counseling & Documentation

New York MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the NY MPJE Exam 1.2 Study Strategy & Federal vs. New York Law Hierarchy

2 Federal Pharmacy Law: Controlled Substances

2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Registration, Forms & Security 2.3 Federal Food, Drug, and Cosmetic Act (FDCA)

3 Federal Pharmacy Law: Privacy & Supply Chain

3.1 HIPAA & Patient Privacy 3.2 OBRA '90, Medicare/Medicaid & DUR 3.3 DSCSA & Drug Supply Chain Integrity

4 Area 1a: NYSED, Board & Pharmacist Licensure

4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137 4.2 Pharmacist Licensure: Education, NAPLEX/MPJE & Internship 4.3 License by Endorsement, Renewal & Continuing Education

5 Area 1b: Interns, Technicians & Discipline

5.1 Pharmacy Interns & Limited Permits 5.2 Registered Pharmacy Technicians (RPhT) & Supervision Ratios 5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs

6 Area 2a: Prescribing, Controlled Substances & Collaborative Practice

6.1 Prescription Requirements & Practitioner Authority 6.2 Controlled Substance Prescribing & the NY EPCS Mandate 6.3 Refills & Authority Limitations 6.4 Collaborative Drug Therapy Management (§6801-a) & Non-Patient-Specific Orders

7 Area 2b: Counseling, Immunization & Public Health

7.1 Patient Counseling & Documentation 7.2 Pharmacist Immunization Authority 7.3 Naloxone Access & Public Health Programs 7.4 Patient Confidentiality & Pharmacy Records

8 Area 3a: Verification, Transfers & DUR/I-STOP

8.1 Legitimate Medical Purpose & Corresponding Responsibility 8.2 Prescription Transfers Between Pharmacies 8.3 Prospective DUR & the I-STOP PMP Registry 8.4 Refill Exceptions & Emergency Dispensing

9 Area 3b: Labeling, Packaging & Substitution

9.1 Labeling of Dispensed Drugs 9.2 Packaging: PPPA & Child-Resistant Containers 9.3 Generic Substitution & Interchangeable Biologics (§6816-a) 9.4 OTC, Behind-the-Counter & Restricted Nonprescription Sales

10 Area 4a: Records, Inventories & Delivery

10.1 Ordering, Acquisition & Distribution Records 10.2 Recordkeeping, Storage & Handling 10.3 Controlled Substance Inventories & BNE Registration 10.4 Delivery & Mail-Order Dispensing

11 Area 4b: Compounding, Central Fill & Facilities

11.1 Compounding: Non-Sterile, Sterile & Hazardous Drugs 11.2 Central Fill, Centralized Processing & Shared Pharmacy Services 11.3 Automated Dispensing & Telepharmacy 11.4 Pharmacy Establishment Registration, Inspections & Discipline

12 Test-Day Strategy & Final Review

12.1 When New York Law Is Stricter Than Federal Law 12.2 Test-Day Strategy & Common Traps

7.1 Patient Counseling & Documentation

Key Takeaways Explain This Topic AI

New York's mandatory offer-to-counsel under 8 NYCRR §63.6 is triggered by a new patient, a new medication, or a change in dose/strength/route/directions -- not by every dispensing event.

On-premises offers must be made in person face-to-face whenever practicable, or by telephone; off-premises/mail-order pharmacies must include a written offer with a callback number, toll-free if mail-order is the primary business.

Patient medication profiles must be maintained in a retrievable form for five years following the date of the most recent entry.

A written leaflet or Medication Guide may supplement counseling but never replaces the pharmacist's personal offer under §63.6.

Required counseling elements include drug name/description, dosage, precautions, side effects/interactions, storage, refill information, and missed-dose instructions.

Last updated: July 2026

Why Counseling Documentation Is Tested on the NY MPJE

New York's pharmacist counseling and documentation obligations sit inside the Pharmacist Practice (33%) content area of the Multistate Pharmacy Jurisprudence Examination (MPJE). The controlling rule is 8 NYCRR §63.6 (Title 8 of the New York Codes, Rules and Regulations, Part 63 — Pharmacy, promulgated under Education Law Article 137). Candidates are expected to know when an offer to counsel must be made, what the offer must contain, how it differs for on-premises versus off-premises (mail-order) dispensing , and how long the resulting patient record must be kept.

The Offer-to-Counsel Standard

Under §63.6, a pharmacist must personally counsel a patient (or the patient's agent) before dispensing a prescription for the first time for a new patient, a new medication, or any change in dose, strength, route of administration, or directions for use of a previously dispensed prescription. Unlike states that require an offer on every fill, New York's trigger is tied to these three specific events, not simply any new prescription paper — but a dose or regimen change is itself an independent, mandatory trigger, not merely a discretionary one.

The offer should occur in person, face-to-face, whenever practicable .

Where an in-person meeting is not practicable, the offer may be made by telephone .

The offer must give the patient a genuine opportunity to ask questions and receive an answer — a pharmacist cannot satisfy §63.6 by silently placing a leaflet in the bag.

Off-Premises and Mail-Order Delivery

When a prescription is delivered off-premises (mail order, courier, or similar), the pharmacist cannot rely on a face-to-face encounter. Instead, §63.6 requires the pharmacy to include with each prescription a written offer to counsel . That written offer must:

State that counseling is available.

Provide a telephone number at which a licensed pharmacist or registered pharmacy intern can be reached.

Use a toll-free number if the pharmacy is engaged primarily in mail-order dispensing.

A mail-order pharmacy that includes only a local, non-toll-free number when it is engaged primarily in mail-order business has not met the §63.6 standard.

What Must Be Covered

When counseling is actually delivered — whether offered and accepted, or initiated by the pharmacist's professional judgment — the topics contemplated by §63.6 include:

  • Element Example content
  • Name and description of the drug Brand/generic name, dosage form
  • Dosage, dosage form, and duration How much, how, how long
  • Special directions and precautions Food/drug interactions, activities to avoid
  • Common severe side effects, interactions, contraindications What to watch for and when to call the prescriber
  • Techniques for self-monitoring e.g., glucose logs, INR awareness
  • Proper storage Refrigeration, light sensitivity, child-resistant closure use
  • Refill information When and how to refill
  • Action in the event of a missed dose What the patient should do if a dose is skipped

New York does not require every element to be recited for every drug; the pharmacist exercises professional judgment about which elements are clinically relevant, but must be prepared to address any of them if the patient asks.

Verbal Offer vs. Written Information

The MPJE frequently tests the distinction between the verbal offer to counsel (required on-premises) and written information (such as a manufacturer Medication Guide or a computer-generated leaflet). A printed leaflet dropped in the bag is a useful supplement , but it does not substitute for the personal offer to counsel required by §63.6. Conversely, for off-premises dispensing, the written offer (with callback number) is itself the compliance mechanism — there is no additional requirement to also place a live phone call.

Documentation and Record Retention

Every patient's counseling interaction lives inside the pharmacy's patient medication profile , which under Part 63 must be maintained in a retrievable form for five years following the date of the most recent entry . In practice this means:

Documenting that an offer was made (not necessarily a transcript of the conversation).

Documenting refusal, if the patient declines.

Keeping the underlying profile — allergies, other medications, refusal notations — retrievable for the full five-year window, even after the patient stops using that pharmacy.

An inspector who finds a profile purged after three years, or a chain that cannot reproduce a 2022 counseling note in 2026, has found a Part 63 violation independent of whether any patient was actually harmed.

Documentation as Risk Management

Beyond satisfying §63.6 on its own terms, the counseling record is the pharmacy's primary evidence in a Board of Pharmacy complaint or a civil malpractice claim. A patient who alleges she was never warned about a serious interaction, or who claims she was never told how to use an inhaler correctly, puts the pharmacy in a far stronger position if the profile shows a dated, initialed note that an offer was made and either accepted with specific elements discussed, or declined. Pharmacies that rely on an unstructured "counseled" checkbox with no date, no initials, and no indication of what was actually covered create a weaker record than one documenting the specific elements addressed — even though §63.6 does not mandate a verbatim transcript. Building consistent documentation habits before an inspection or a complaint arrives is far easier than reconstructing practice from memory afterward.

Common MPJE Traps

Treating counseling and the offer to counsel as the same event — the statute requires an offer ; actual counseling is required only if the offer is accepted.

Assuming refills always require a fresh offer — §63.6's mandatory triggers are a new patient, a new medication, or a change in dose/strength/route/directions, not every dispensing event; a same-dose refill with no regimen change does not by itself retrigger the counseling requirement.

Confusing New York's profile retention period ( five years ) with other states' retention periods or with federal HIPAA retention expectations, which are governed separately.